Sponsor: 
Pfizer Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Meningococcal B vaccines

Registered for use in children aged ≥10 years and in adults.

MenB-fHBP — recombinant lipidated factor H binding protein meningococcal serogroup B vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 60 µg Neisseria meningitidis serogroup B factor H binding protein subfamily A
  • 60 µg Neisseria meningitidis serogroup B factor H binding protein subfamily B

May contain traces of:

  • histidine
  • aluminium phosphate
  • polysorbate 80

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018